Market Forecast by Types (services, software, equipment, and consumables), by Applications (regenerative medicine, clinical research and life science research), By Sample Types (blood products, human tissues, nucleic acids, cell lines, biological fluids, and human waste products) and by Regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) and Competitive Landscape
Product Code: ETC037261 | Publication Date: Nov 2020 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 |
Report Name | Biobanking Market |
Report Category / Coverage | Global |
Forecast Period | 2024-2030 |
CAGR | 12% |
Market Size | USD 68 billion by 2030 |
Growing Sector | Life science research |
Biobanking Market report thoroughly covers the by sample type, by type, by application, and by region. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
The Biobanking market has been experiencing significant growth over the past few years. As of 2024, the global market is valued at approximately $34 billion. Further, the Global Market is projected to expand at a CAGR of 12% from 2024 to 2030. Additionally, by 2030, the market size is expected to reach around $68 billion.
The biobanking market has been experiencing significant growth due to advancements in healthcare technologies and an increasing demand for personalized medicine. Biobanks store biological samples such as blood, tissue, and DNA, which are critical for medical research, disease prevention, and the development of new treatments. This market is driven by the rising prevalence of chronic diseases, the need for effective therapeutics, and supportive government initiatives for biological research. Additionally, the integration of big data and artificial intelligence in biobanks is enhancing research efficiency and data management. Nevertheless, the market faces challenges like ethical concerns regarding data privacy and standardization issues across different biobanking facilities.
According to 6Wresearch, the Biobanking Market revenue is expected to reach at a significant CAGR of 12% during the forecast period 2024-2030. One of the primary drivers is the increasing demand for personalized medicine, which relies on large-scale genetic and biological data to tailor treatments to individual patients. Advances in technology, particularly in the fields of genomics and data analytics, have made it easier to collect, store, and analyze biological specimens, further fueling market expansion. Additionally, a growing number of research initiatives focused on understanding various diseases and developing new drug therapies are contributing to the rising necessity for comprehensive biobank repositories.
Ethical and legal issues concerning the collection and use of human biological materials continue to generate debate, posing significant operational hurdles for biobanks. Similarly, maintaining the privacy and confidentiality of donor information is a persistent challenge that requires robust data management and security solutions. Furthermore, the standardization of processes and compliance with regulatory requirements across different regions can make the management of biobanks intricate and resource-intensive.
A few major companies are driving innovation and growing their global presence in the biobanking sector. Leading businesses in this industry include Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific. Thermo Fisher Scientific is renowned for offering a wide range of biobanking solutions, including data management software and storage hardware. The cutting-edge sample and test technologies offered by Qiagen N.V. are essential to the smooth running of biobanks. Another big company, Merck KGaA, provides cutting-edge goods and services that promote the upkeep and development of biobanking procedures.
The biobanking market is increasingly shaped by comprehensive government regulations designed to ensure ethical practices, quality control, and data protection. These regulations are aimed at standardizing the collection, storage, and use of biological samples, thereby promoting transparency and safeguarding public trust. In many regions, regulatory frameworks require clear consent protocols to ensure donors are informed of how their biological materials will be used. Additionally, regulations often mandate strict measures for data privacy and security to protect donor information from unauthorized access or breaches. As biobanking continues to expand, the role of government oversight becomes ever more critical in maintaining ethical standards and fostering scientific progress.
The biobanking market is poised for significant growth in the coming years, driven by advancements in personalized medicine, genomics, and regenerative medicine. As the demand for precision medicine increases, biobanks will play a crucial role in providing high-quality, well-characterized biological samples that are essential for research and development. The integration of artificial intelligence and machine learning in biobank data management will enhance the efficiency and accuracy of sample analysis, offering deeper insights into disease mechanisms and treatment options. Furthermore, the expansion of collaborations and networks among biobanks is expected to enhance the standardization and sharing of data across borders, fostering innovation and accelerating biomedical discoveries.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
According to Ravi Bhandari, Research Head, 6wresearch, the bio-banking market plays a crucial role in advancing medical research and healthcare innovation. Bio-banks store biological samples, such as tissues, cells, blood, and DNA, which are vital for conducting a wide range of studies, including disease research, drug development, and genetic analysis. The services offered by bio-banks include collection, processing, storage, and distribution of these samples, ensuring their quality and integrity over time. As personalized medicine becomes more prevalent, the demand for bio-banking services is expected to grow significantly.
Life science research plays a pivotal role in the burgeoning bio-banking market, which has become an integral component of modern medical and scientific advancements. Bio-banking involves the collection, processing, storage, and distribution of biological samples, such as blood, tissues, and DNA, that are crucial for research and clinical use. The increased demand for personalized medicine and genomics has accelerated the need for large-scale bio-banking efforts, enabling researchers to store vast amounts of genetic information. This wealth of data provides a foundation for understanding complex diseases, discovering biomarkers, and developing targeted therapies.
The biobanking market for human tissue is witnessing rapid growth, driven by advancements in personalized medicine, research in genomics, and an increasing need for high-quality biological samples. Human tissue samples are critical for a wide range of applications including disease research, drug development, and therapeutic studies. Biobanks serve as important repositories, collecting, storing, and managing these valuable resources while ensuring ethical and regulatory compliance. As the demand for precise medical research intensifies, the role of human tissue in bio banking expands, offering insights into complex diseases and facilitating major breakthroughs in treatment and diagnosis.
North America plays a pivotal role in the biobanking market, driven by advanced healthcare infrastructure, significant investments in research and development, and a strong presence of key industry players. The region's robust regulatory framework and supportive government initiatives have facilitated the growth and standardization of biobanking practices. Additionally, North America hosts a large number of biobanks associated with academic institutions, research centers, and hospitals, which contribute to the collection and storage of vast amounts of biological samples. These resources are crucial for advancing personalized medicine, genomics, and drug discovery.
1. Executive Summary |
2. Introduction |
2.1. Report Description |
2.2. Key Highlights |
2.3. Market Scope & Segmentation |
2.4. Research Methodology |
2.5. Assumptions |
3. Biobanking Market Overview |
3.1. Biobanking Market Revenues, 2020-2030F |
3.2. Biobanking Market Revenue Share, By Type, 2020 & 2030F |
3.3. Biobanking Market Revenue Share, By Applications, 2020 & 2030F |
3.4. Biobanking Market Revenue Share, By Sample Type, 2020 & 2030F |
3.5. Biobanking Market Revenue Share, By Regions, 2020 & 2030F |
3.6. Biobanking Market Industry Life Cycle |
3.7. Biobanking Market- Porter’s Five Forces |
4. Biobanking Market Dynamics |
4.1. Impact Analysis |
4.2. Market Drivers |
4.3. Market Restraints |
5. Biobanking Market Trends |
6. Biobanking Market Overview, By Type |
6.1. Biobanking Market Revenues, By Services, 2020-2030F |
6.2. Biobanking Market Revenues, By Software, 2020-2030F |
6.3. Biobanking Market Revenues, By Equipment, 2020-2030F |
6.4. Biobanking Market Revenues, By Consumables, 2020-2030F |
7. Biobanking Market Overview, By Applications |
7.1. Biobanking Market Revenues, By Clinical Research, 2020-2030F |
7.2. Biobanking Market Revenues, By Life Science Research, 2020-2030F |
7.3. Biobanking Market Revenues, By Regenerative Medicine, 2020-2030F |
8. Biobanking Market Overview, By Sample Type |
8.1. Biobanking Market Revenues, By Blood Products, 2020-2030F |
8.2. Biobanking Market Revenues, By Human Tissues, 2020-2030F |
8.3. Biobanking Market Revenues, By Nucleic Acids, 2020-2030F |
8.4. Biobanking Market Revenues, By Cell Lines, 2020-2030F |
8.5. Biobanking Market Revenues, By Biological Fluids, 2020-2030F |
8.6. Biobanking Market Revenues, By Human Waste Products, 2020-2030F |
9. Asia Pacific Biobanking Market Overview |
9.1. Asia Pacific Biobanking Market Revenues, 2020-2030F |
9.2. Asia Pacific Biobanking Market Revenue Share, By Type, 2020 & 2030F |
9.3. Asia Pacific Biobanking Market Revenue Share, By Applications, 2020 & 2030F |
9.4. Asia Pacific Biobanking Market Revenue Share, By Sample Type, 2020 & 2030F |
9.5. Asia Pacific Biobanking Market Revenue Share, By Countries, 2020 & 2030F |
10. North America Biobanking Market Overview |
10.1. North America Biobanking Market Revenues, 2020-2030F |
10.2. North America Biobanking Market Revenue Share, By Type, 2020 & 2030F |
10.3. North America Biobanking Market Revenue Share, By Applications, 2020 & 2030F |
10.4. North America Biobanking Market Revenue Share, By Sample Type, 2020 & 2030F |
10.5. North America Biobanking Market Revenue Share, By Countries, 2020 & 2030F |
11. Latin America Biobanking Market Overview |
11.1. Latin America Biobanking Market Revenues, 2020-2030F |
11.2. Latin America Biobanking Market Revenue Share, By Type, 2020 & 2030F |
11.3. Latin America Biobanking Market Revenue Share, By Applications, 2020 & 2030F |
11.4. Latin America Biobanking Market Revenue Share, By Sample Type, 2020 & 2030F |
11.5. Latin America Biobanking Market Revenue Share, By Countries, 2020 & 2030F |
12. Europe Biobanking Market Overview |
12.1. Europe Biobanking Market Revenues, 2020-2030F |
12.2. Europe Biobanking Market Revenue Share, By Type, 2020 & 2030F |
12.3. Europe Biobanking Market Revenue Share, By Applications, 2020 & 2030F |
12.4. Europe Biobanking Market Revenue Share, By Sample Type, 2020 & 2030F |
12.5. Europe Biobanking Market Revenue Share, By Countries, 2020 & 2030F |
13. Middle East Biobanking Market Overview |
13.1. Middle East Biobanking Market Revenues, 2020-2030F |
13.2. Middle East Biobanking Market Revenue Share, By Type, 2020 & 2030F |
13.3. Middle East Biobanking Market Revenue Share, By Applications, 2020 & 2030F |
13.4. Middle East Biobanking Market Revenue Share, By Sample Type, 2020 & 2030F |
13.5. Middle East Biobanking Market Revenue Share, By Countries, 2020 & 2030F |
14. Africa Biobanking Market Overview |
14.1. Africa Biobanking Market Revenues, 2020-2030F |
14.2. Africa Biobanking Market Revenue Share, By Type, 2020 & 2030F |
14.3. Africa Biobanking Market Revenue Share, By Applications, 2020 & 2030F |
14.4. Africa Biobanking Market Revenue Share, By Sample Type, 2020 & 2030F |
14.5. Africa Biobanking Market Revenue Share, By Countries, 2020 & 2030F |
15. Biobanking Market Competitive Landscape |
15.1. Biobanking Market, By Companies, 2023 |
15.2. Asia Pacific Biobanking Market, By Companies, 2023 |
15.3. North America Biobanking Market, By Companies, 2023 |
15.4. Latin America Biobanking Market, By Companies, 2023 |
15.5. Europe Biobanking Market, By Companies, 2023 |
15.7. Middle East Biobanking Market, By Companies, 2023 |
15.8. Africa Biobanking Market, By Companies, 2023 |
16. Company Profiles |
17. Key Strategic Recommendations |